| The ferric uptake regulator (Fur) protein from Bradyrhizobium japonicum is an iron-responsive transcriptional repressor in vitro YE Friedman, MR O'Brian Journal of Biological Chemistry 279 (31), 32100-32105, 2004 | 65 | 2004 |
| A novel DNA-binding site for the ferric uptake regulator (Fur) protein from Bradyrhizobium japonicum YE Friedman, MR O'Brian Journal of Biological Chemistry 278 (40), 38395-38401, 2003 | 63 | 2003 |
| Building biotechnology: Starting, managing, and understanding biotechnology companies Y Friedman ThinkBiotech, 2006 | 46 | 2006 |
| Location of pharmaceutical innovation: 2000-2009 Y Friedman Nature reviews. Drug discovery 9 (11), 835, 2010 | 42 | 2010 |
| Building Biotechnology: Business, Regulations, Patents, Law Y Friedman Politics, Science. Washington, DC: Logos Press, 2008 | 9 | 2008 |
| Time for a new business model? Y Friedman Journal of Commercial Biotechnology 16 (1), 1-2, 2010 | 8 | 2010 |
| Building Biotechnology: Starting Y Friedman Managing, and Understanding Biotechnology Companies-Business Development …, 2006 | 7 | 2006 |
| Best practices in biotechnology business development Y Friedman Journal of Commercial Biotechnology 14, 365-367, 2008 | 6 | 2008 |
| Generic drug launch dates–a 1-step solution to navigate the web of drug patents and regulatory protections (2020) F Yali | 6 | |
| Best practices in Biotechnology education Y Friedman Logos Press, 2008 | 5 | 2008 |
| Building biotechnology: Business· regulations· patents· law· policy· science Y Friedman [KIIP] 한국지식재산연구원 도서 DB, 0-0, 2013 | 4 | 2013 |
| The business of biotechnology: profit from the expanding influence of biotechnology Y Friedman Logos Press, 2007 | 4 | 2007 |
| Applying design thinking to biotechnology Y Friedman Journal of Commercial Biotechnology 17 (1), 1-1, 2011 | 3 | 2011 |
| Science Business: The Promise, the reality, and the future of biotech. By Gary P. Pisano Y Friedman Biotechnology Journal: Healthcare Nutrition Technology 1 (12), 1474-1474, 2006 | 3 | 2006 |
| Cross-border biotech YE Friedman, RS Seline Nature biotechnology 23 (6), 656-657, 2005 | 3 | 2005 |
| Could personalized medicine be the driver for widespread price controls? Y Friedman Journal of Commercial Biotechnology 18 (3), 2012 | 2 | 2012 |
| Intellectual property and biotechnology innovation: To protect or not protect? Y Friedman Journal of Commercial Biotechnology 15 (4), 285-286, 2009 | 2 | 2009 |
| The impact of the global financial crisis on biotechnology development Y Friedman Journal of Commercial Biotechnology 15 (3), 195-196, 2009 | 2 | 2009 |
| Biotechnology commercialisation: Getting past the technology-push Y Friedman Journal of Commercial Biotechnology 15 (1), 1-2, 2009 | 2 | 2009 |
| Continuing education in biotechnology Y Friedman Journal of Commercial Biotechnology 14 (4), 275-276, 2008 | 2 | 2008 |
